Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and
immunogenicity of QGE031 in Japanese atopic male subjects in order to determine the
eligibility of Japanese patients in subsequent clinical studies.